Page last updated: 2024-09-03

cgs 25462 and phosphoramidon

cgs 25462 has been researched along with phosphoramidon in 1 studies

Compound Research Comparison

Studies
(cgs 25462)
Trials
(cgs 25462)
Recent Studies (post-2010)
(cgs 25462)
Studies
(phosphoramidon)
Trials
(phosphoramidon)
Recent Studies (post-2010) (phosphoramidon)
7007811233

Protein Interaction Comparison

ProteinTaxonomycgs 25462 (IC50)phosphoramidon (IC50)
ThermolysinBacillus thermoproteolyticus0.033
NeprilysinRattus norvegicus (Norway rat)0.0578
NeprilysinOryctolagus cuniculus (rabbit)0.0028
NeprilysinHomo sapiens (human)0.0405
Angiotensin-converting enzyme Homo sapiens (human)0.615
Endothelin-converting enzyme 1Homo sapiens (human)1.0695
P2Y purinoceptor 12Homo sapiens (human)0.017

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berry, C; Blanchard, L; De Lombaert, S; el-Chehabi, L; Erion, MD; Ghai, RD; Sakane, Y; Tan, J; Trapani, AJ1

Other Studies

1 other study(ies) available for cgs 25462 and phosphoramidon

ArticleYear
N-Phosphonomethyl dipeptides and their phosphonate prodrugs, a new generation of neutral endopeptidase (NEP, EC 3.4.24.11) inhibitors.
    Journal of medicinal chemistry, 1994, Feb-18, Volume: 37, Issue:4

    Topics: Animals; Antihypertensive Agents; Biological Availability; Biphenyl Compounds; Blood Pressure; Half-Life; Neprilysin; Organophosphonates; Phenylalanine; Phosphopeptides; Prodrugs; Rats; Structure-Activity Relationship

1994